Ing Investment Management »

Halozyme Therapeutics shares owned by Ing Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $196M 195M 1.01

More positions owned by Ing Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Servicenow (NOW)
JPMorgan Chase & Co. (JPM)
Wells Fargo Perp Pfd Cnv A (WFC.PL)
Palo Alto Networks (PANW)
Datadog Cl A Com (DDOG)

View all positions for Ing Investment Management

Top funds holding Halozyme Therapeutics

Ing Investment Management
Invesco
Davidson Kempner Capital Management
Wellesley Investment Advisors
Lazard Asset Management
BlackRock
BlackRock
Calamos Advisors
III Capital Management
Shenkman Capital Management
Aviva
Advent Capital Management
CNH Partners
State Street Corporation
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Halozyme Therapeutics